Artwork

内容由Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP提供。所有播客内容(包括剧集、图形和播客描述)均由 Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Ep. 367 The Metabolic Health Crisis & GLP-1s with Dr. Anurag Singh

42:00
 
分享
 

Manage episode 422044181 series 2437481
内容由Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP提供。所有播客内容(包括剧集、图形和播客描述)均由 Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

I am delighted to reconnect with Dr. Anurag Singh today, the Chief Medical Officer at Timeline Nutrition. He joined me once before on Episode 268.

I invited Dr. Singh back to discuss the latest research on GLP-1 agonists like Wegovy, Semaglutide, and Ozempic, which are gaining significant traction with projected sales exceeding $100 billion by 2030, potentially affecting 9% of the US population.

In our conversation, we explore the contributors to our metabolic health crisis by looking at the research surrounding GLP-1 agonists, the physiology of GLP-1 peptides, and the influencing elements Dr. Singh refers to as the trifecta. We dive into the loss of muscle mass and strength, sarcopenia, and frailty associated with these drugs, and Dr. Singh shares his concerns about their impact on bone health, the gut microbiome, and their use in younger patients. We also get into lifestyle measures, mitochondrial health, hallmarks of aging, Akkermansia, and the importance of advocacy and patient empowerment.

Today’s compelling and invaluable discussion with Dr. Anurag Singh highlights crucial insights into GLP-1 agonists and their broader health implications. I know it will provide significant value for our listeners.

IN THIS EPISODE YOU WILL LEARN:

  • Dr. Singh breaks down what GLP-1 agonist drugs are and how they work.
  • How our modern-day lifestyles contribute to poor metabolic health
  • The benefits and side-effects of using GLP-1 agonist treatments for improving metabolic health
  • Why strength training is essential for preventing muscle loss and frailty in middle-aged women
  • What are the potential long-term effects of SARMs on muscle mass and health?
  • Why dietary counseling is essential for those taking GLP-1 agonist drugs
  • The benefits of supplements for boosting mitochondrial health
  • Dr. Singh discusses a research study on combining lithium with GLP-1 agonists to improve the muscle quality of those with muscle-wasting conditions.
  • Why akkermansia is essential for GLP production

Connect with Cynthia Thurlow

Connect with Dr. Anurag Singh

Previous Episode Mentioned

Ep. 268: Understanding the Biology of Aging with Evolved Supplementation and Nutrition, featuring Dr. Anurag Singh

  continue reading

391集单集

Artwork
icon分享
 
Manage episode 422044181 series 2437481
内容由Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP提供。所有播客内容(包括剧集、图形和播客描述)均由 Cynthia Thurlow, Everyday Wellness: Cynthia Thurlow, and NP 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

I am delighted to reconnect with Dr. Anurag Singh today, the Chief Medical Officer at Timeline Nutrition. He joined me once before on Episode 268.

I invited Dr. Singh back to discuss the latest research on GLP-1 agonists like Wegovy, Semaglutide, and Ozempic, which are gaining significant traction with projected sales exceeding $100 billion by 2030, potentially affecting 9% of the US population.

In our conversation, we explore the contributors to our metabolic health crisis by looking at the research surrounding GLP-1 agonists, the physiology of GLP-1 peptides, and the influencing elements Dr. Singh refers to as the trifecta. We dive into the loss of muscle mass and strength, sarcopenia, and frailty associated with these drugs, and Dr. Singh shares his concerns about their impact on bone health, the gut microbiome, and their use in younger patients. We also get into lifestyle measures, mitochondrial health, hallmarks of aging, Akkermansia, and the importance of advocacy and patient empowerment.

Today’s compelling and invaluable discussion with Dr. Anurag Singh highlights crucial insights into GLP-1 agonists and their broader health implications. I know it will provide significant value for our listeners.

IN THIS EPISODE YOU WILL LEARN:

  • Dr. Singh breaks down what GLP-1 agonist drugs are and how they work.
  • How our modern-day lifestyles contribute to poor metabolic health
  • The benefits and side-effects of using GLP-1 agonist treatments for improving metabolic health
  • Why strength training is essential for preventing muscle loss and frailty in middle-aged women
  • What are the potential long-term effects of SARMs on muscle mass and health?
  • Why dietary counseling is essential for those taking GLP-1 agonist drugs
  • The benefits of supplements for boosting mitochondrial health
  • Dr. Singh discusses a research study on combining lithium with GLP-1 agonists to improve the muscle quality of those with muscle-wasting conditions.
  • Why akkermansia is essential for GLP production

Connect with Cynthia Thurlow

Connect with Dr. Anurag Singh

Previous Episode Mentioned

Ep. 268: Understanding the Biology of Aging with Evolved Supplementation and Nutrition, featuring Dr. Anurag Singh

  continue reading

391集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南